Qiaoling Li Selected Research

L 30 (L-30)

1/2022

Early predictors of lung necrosis severity in children with community-acquired necrotizing pneumonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiaoling Li Research Topics

Disease

6	Infections 01/2021 - 01/2013
4	Neoplasms (Cancer) 01/2022 - 01/2012
3	Myocardial Infarction 07/2021 - 01/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2016
2	Inflammation (Inflammations) 02/2022 - 01/2020
2	Necrosis 01/2022 - 08/2020
2	Hypertension (High Blood Pressure) 07/2021 - 01/2020
2	Brain Ischemia (Cerebral Ischemia) 08/2020 - 01/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2020 - 01/2019
1	Left Ventricular Dysfunction 02/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Diabetes Mellitus 12/2020
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Dyslipidemias (Dyslipidemia) 12/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020
1	Ischemic Stroke 08/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2020
1	Atherosclerosis 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Hemorrhage 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Hyperplasia 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Neointima 01/2020
1	Infarction (Infarctions) 12/2019
1	Cognitive Dysfunction 10/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2019
1	Pituitary Neoplasms (Pituitary Adenoma) 06/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Cerebral Infarction 01/2019
1	Brain Edema (Cerebral Edema) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Neurologic Manifestations (Neurological Manifestations) 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2018
1	Carcinogenesis 02/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2018
1	Uterine Cervical Dysplasia 02/2018
1	Neoplasm Metastasis (Metastasis) 04/2016

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2016
3	Therapeutic UsesIBA 01/2022 - 09/2019
2	Serum AlbuminIBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2016
2	florfenicolIBA 01/2021 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 12/2020 - 01/2019
2	Streptozocin (Streptozotocin)FDA Link 12/2020 - 01/2019
2	HMGB1 Protein (HMG1)IBA 08/2020 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2022
1	2-hexyl-4-pentynoic acidIBA 01/2022
1	L 30 (L-30)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Kanamycin KinaseIBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	AminoglycosidesIBA 01/2021
1	CoagulaseIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2020
1	punicalaginIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 08/2020
1	Complement Factor B (Factor B)IBA 08/2020
1	Oxygen (Dioxygen)IBA 08/2020
1	NF-kappa B (NF-kB)IBA 08/2020
1	Toll-Like Receptor 4IBA 08/2020
1	LipidsIBA 01/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	ColforsinIBA 01/2020
1	Gallic AcidIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Heme (Haem)IBA 01/2020
1	PCSK9 InhibitorsIBA 01/2020
1	IronIBA 01/2020
1	CholesterolIBA 01/2020
1	Long Noncoding RNAIBA 12/2019
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 10/2019
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 06/2019
1	Ubiquitin-Conjugating EnzymesIBA 06/2019
1	GlypicansIBA 06/2019
1	Polycomb Repressive Complex 1IBA 06/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Ellagic AcidIBA 01/2019
1	EnzymesIBA 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	luteolin-7-glucosideIBA 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2019
1	AntioxidantsIBA 01/2019
1	CreatinineIBA 01/2019
1	Messenger RNA (mRNA)IBA 02/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2018
1	Histidine (L-Histidine)FDA Link 02/2018

Therapy/Procedure

4	Therapeutics 12/2020 - 09/2006
1	Percutaneous Coronary Intervention 01/2020
1	Intravenous Administration 04/2016